Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses

• Siri L. Feruglio,

  Affiliation Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Marius Trøseid,

  Affiliation Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway

  ⨯
• Jan Kristian Damås,

  Affiliations Department of Infectious Diseases, St. Olavs Hospital, Trondheim, Norway, Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Dag Kvale,

  Affiliations Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway

  ⨯
• Anne Ma Dyrhol-Riise

  * E-mail: a.m.d.riise@medisin.uio.no

  Affiliations Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, Department of Clinical Science, University of Bergen, Bergen, Norway

  ⨯